RDA Financial Network’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-33,632	Closed	-$2.63M	–	266
2025 Q2	$2.63M	Sell	33,632 -1,064	-3%	-$79.4K	0.71%	32
2025 Q1	$2.51M	Buy	34,696 +926	+3%	+$66.3K	0.75%	34
2024 Q4	$2.5M	Buy	33,770 +523	+2%	+$36.6K	0.73%	31
2024 Q3	$2.19M	Buy	33,247 +2,417	+8%	+$176K	0.68%	37
2024 Q2	$2.85M	Buy	30,830 +6,357	+26%	+$563K	0.93%	25
2024 Q1	$2.34M	Buy	24,473 +986	+4%	+$82.8K	0.8%	34
2023 Q4	$1.79M	Buy	23,487 +2,729	+13%	+$190K	0.68%	43
2023 Q3	$1.44M	Buy	20,758 +928	+5%	+$74.6K	0.62%	50
2023 Q2	$1.87M	Sell	19,830 -300	-1%	-$26.1K	0.79%	38
2023 Q1	$1.67M	Buy	20,130 +714	+4%	+$56.1K	0.76%	39
2022 Q4	$1.45M	Sell	19,416 -1,305	-6%	-$101K	0.73%	43
2022 Q3	$1.71M	Buy	20,721 +184	+0.9%	+$17.7K	0.93%	28
2022 Q2	$1.95M	Buy	20,537 +461	+2%	+$47.7K	0.99%	27
2022 Q1	$2.36M	Buy	20,076 +1,202	+6%	+$135K	1%	28
2021 Q4	$2.44M	Buy	18,874 +390	+2%	+$45.5K	1%	30
2021 Q3	$2.09M	Buy	18,484 +117	+0.6%	+$13.4K	0.92%	35
2021 Q2	$1.9M	Buy	18,367 +563	+3%	+$53.1K	0.84%	37
2021 Q1	$1.49M	Buy	17,804 +961	+6%	+$81.2K	0.64%	47
2020 Q4	$1.54M	Buy	16,843 +2,051	+14%	+$170K	0.69%	43
2020 Q3	$1.18M	Buy	14,792 +471	+3%	+$36.8K	0.54%	53
2020 Q2	$990K	Buy	14,321 +827	+6%	+$58.8K	0.49%	58
2020 Q1	$848K	Buy	13,494 +1,014	+8%	+$73.1K	0.51%	53
2019 Q4	$968K	Buy	12,480 +111	+0.9%	+$8.67K	0.39%	64
2019 Q3	$1M	Sell	12,369 -570	-4%	-$40K	0.43%	64
2019 Q2	$805K	Buy	12,939 +840	+7%	+$50.8K	0.36%	77
2019 Q1	$763K	Buy	+12,099	New	+$690K	0.36%	74